A Perfect MASH Comparing Resmetirom and GLP-1 Agonists for Metabolic-Associated Steatohepatitis: What Does the Current Evidence Suggest?
1. 请及时下载文件确认是否正确, 系统将在 2026-03-16 16:23:53 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
J Lin, V Green, A Sohal, M Roytman
Journal of Clinical …, 2025
journals.lww.com
… as HSD17B13 have been noted to be protective against MASH, and current studies are
aiming to alter gene expression related to liver-specific MASH progression, 79 while GLP-1 RAs …

